These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30949443)

  • 21. FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer.
    Marmé F; Werft W; Benner A; Burwinkel B; Sinn P; Sohn C; Lichter P; Hahn M; Schneeweiss A
    Ann Oncol; 2010 Aug; 21(8):1636-1642. PubMed ID: 20147743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.
    Farnebo L; Tiefenböck K; Ansell A; Thunell LK; Garvin S; Roberg K
    Int J Cancer; 2013 Oct; 133(8):1994-2003. PubMed ID: 23564498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.
    Ipenburg NA; Koole K; Liem KS; van Kempen PM; Koole R; van Diest PJ; van Es RJ; Willems SM
    Target Oncol; 2016 Feb; 11(1):17-27. PubMed ID: 26115874
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Kim JH; Jeong SY; Jang HJ; Park ST; Kim HS
    Front Oncol; 2021; 11():762528. PubMed ID: 34737965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma.
    Choi KY; Rho YS; Kwon KH; Chung EJ; Kim JH; Park IS; Lee DJ
    Cancer Biomark; 2012-2013; 12(3):115-24. PubMed ID: 23481570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma.
    Koole K; van Kempen PM; van Bockel LW; Smets T; van der Klooster Z; Dutman AC; Peeters T; Koole R; van Diest P; van Es RJ; Willems SM
    Pathobiology; 2015; 82(6):280-9. PubMed ID: 26551585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
    Xu B; Tong N; Chen SQ; Hua LX; Wang ZJ; Zhang ZD; Chen M
    BMC Cancer; 2011 Feb; 11():84. PubMed ID: 21349172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
    Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
    Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer.
    Ansell A; Farnebo L; Grénman R; Roberg K; Thunell LK
    Oral Oncol; 2009 Jan; 45(1):23-9. PubMed ID: 18487077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
    Chen TH; Yang SF; Liu YF; Lin WL; Han CP; Wang PH
    Reprod Sci; 2018 Jan; 25(1):86-93. PubMed ID: 28378614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility.
    Chou CH; Hsieh MJ; Chuang CY; Lin JT; Yeh CM; Tseng PY; Yang SF; Chen MK; Lin CW
    Oncotarget; 2017 Nov; 8(56):96225-96238. PubMed ID: 29221201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis.
    Lang L; Xiong Y; Prieto-Dominguez N; Loveless R; Jensen C; Shay C; Teng Y
    J Exp Clin Cancer Res; 2021 Mar; 40(1):93. PubMed ID: 33691750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet.
    Lutz SZ; Hennige AM; Peter A; Kovarova M; Totsikas C; Machann J; Kröber SM; Sperl B; Schleicher E; Schick F; Heni M; Ullrich A; Häring HU; Stefan N
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2041-2053. PubMed ID: 30541128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.
    Choi CH; Chung JY; Kim JH; Kim BG; Hewitt SM
    J Transl Med; 2016 May; 14(1):124. PubMed ID: 27154171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer.
    Wei W; You Z; Sun S; Wang Y; Zhang X; Pang D; Jiang Y
    Mol Carcinog; 2018 Aug; 57(8):988-996. PubMed ID: 29603419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
    Bange J; Prechtl D; Cheburkin Y; Specht K; Harbeck N; Schmitt M; Knyazeva T; Müller S; Gärtner S; Sures I; Wang H; Imyanitov E; Häring HU; Knayzev P; Iacobelli S; Höfler H; Ullrich A
    Cancer Res; 2002 Feb; 62(3):840-7. PubMed ID: 11830541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.
    Marmé F; Hielscher T; Hug S; Bondong S; Zeillinger R; Castillo-Tong DC; Sehouli J; Braicu I; Vergote I; Isabella C; Mahner S; Ferschke I; Rom J; Sohn C; Schneeweiss A; Altevogt P
    Int J Cancer; 2012 Aug; 131(4):E586-91. PubMed ID: 22034009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between fibroblast growth factor receptor 4 Gly388Arg polymorphism and ischaemic stroke.
    Zhang HF; Zhao KJ; Yang PF; Fang YB; Zhang YH; Liu JM; Huang QH
    J Int Med Res; 2012; 40(5):1708-14. PubMed ID: 23206452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor receptor 4 Gly388Arg polymorphism associated with severity of gallstone disease in a Chinese population.
    Chen Q; Li WJ; Wan YY; Yu CD; Li WG
    Genet Mol Res; 2012 Mar; 11(1):548-55. PubMed ID: 22535390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.